Alternatives to Nevirapine If You Can't Fill Your Prescription

Nevirapine is one of the oldest antiretroviral drugs still in use, but it is no longer the first choice in U.S. HIV treatment guidelines. If your pharmacy can't fill your nevirapine prescription, or if you and your provider are considering a switch, there are several alternatives worth knowing about. This guide covers the most relevant options — all in the NNRTI class or serving a similar role.

Important: Never stop taking antiretroviral therapy on your own. Any changes to your HIV regimen must be made with your prescriber. Stopping nevirapine abruptly can allow HIV to replicate and develop resistance.

Why Your Provider Might Switch You Off Nevirapine Anyway

Nevirapine is no longer recommended as a preferred first-line HIV treatment in U.S., European, or WHO guidelines for adults and adolescents — largely due to its risk of severe hepatotoxicity (liver damage) and skin reactions, especially early in treatment. Newer NNRTIs and integrase inhibitors have better safety and tolerability profiles. If you're still on nevirapine, it's worth discussing with your provider whether a switch might benefit you.

Alternative #1: Efavirenz (Sustiva) — The Classic Comparison

Efavirenz (brand name Sustiva; also found in the combination tablet Atripla with emtricitabine and tenofovir) is another first-generation NNRTI. Like nevirapine, it was a cornerstone of HIV therapy for many years. It is taken once daily and generic versions are widely available.

Key differences from nevirapine:

Lower hepatotoxicity risk but significant neuropsychiatric side effects (vivid dreams, dizziness, mood changes)

No CD4 count restriction for initiation (unlike nevirapine)

Similar resistance patterns — K103N mutation confers resistance to both

Generally more widely stocked at pharmacies than nevirapine

Alternative #2: Rilpivirine (Edurant) — A Second-Generation Upgrade

Rilpivirine (brand name Edurant) is a second-generation NNRTI with improved tolerability over both nevirapine and efavirenz. It is also found in combination tablets like Complera (rilpivirine + emtricitabine + tenofovir DF), Odefsey (with emtricitabine + tenofovir AF), and Juluca (with dolutegravir).

Key considerations for rilpivirine:

Must be taken with a full meal (≥500 calories) for adequate absorption

Recommended only for patients with HIV viral load below 100,000 copies/mL at baseline

Cannot be combined with proton pump inhibitors (PPIs) like omeprazole

Better tolerated than nevirapine — fewer liver safety concerns

Alternative #3: Doravirine (Pifeltro) — The Newest NNRTI

Doravirine (brand name Pifeltro) was approved in 2018 and is the newest NNRTI available. It is also available in the combination tablet Delstrigo (doravirine + lamivudine + tenofovir DF). Doravirine offers several advantages:

No food restrictions — can be taken with or without food

Fewer neuropsychiatric side effects than efavirenz

Active against some NNRTI-resistant strains (e.g., K103N) that would make nevirapine or efavirenz ineffective

Once daily; not an inducer of CYP3A4, so fewer drug interactions than nevirapine

38,912+ patients found their medications in stock

38K+

Find Nevirapine In Stock Today →

Alternative #4: Etravirine (Intelence) — For Treatment-Experienced Patients

Etravirine (brand name Intelence) is a second-generation NNRTI approved specifically for treatment-experienced patients who have NNRTI resistance. It retains activity against some strains that are resistant to nevirapine. However, it is taken twice daily and is generally not used for treatment-naive patients.

What About Integrase Inhibitors?

Today's preferred HIV regimens in U.S. guidelines are often built around integrase strand transfer inhibitors (INSTIs) like dolutegravir (Tivicay), bictegravir (found in Biktarvy), or cabotegravir (Vocabria). These drugs have a different mechanism than nevirapine and can be used when NNRTI resistance is present. Your provider may recommend an INSTI-based regimen instead, depending on your resistance profile and medical history.

Skip the calls, skip the stress.

Find Nevirapine In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

How to Talk to Your Doctor About Switching

Before any switch is made, your provider will typically review your HIV resistance test results, your current viral load and CD4 count, any side effects you're experiencing, your other medications (for drug interactions), and your insurance coverage. No two patients are the same, and the best alternative to nevirapine depends on your full clinical picture.

If the immediate problem is just locating nevirapine in stock, see our guide on how to find nevirapine near you before making any medication changes.